76 related articles for article (PubMed ID: 4443131)
1. Studies on the therapeutic use of mercurascan (MSC). Part 1: Distribution of mercurascan in the body in experimental and clinical myocardial ischaemia.
Málek P; Vavrejn B; Kolc J; Ratuský J
Int J Clin Pharmacol; 1974 Dec; 10(4):266-72. PubMed ID: 4443131
[No Abstract] [Full Text] [Related]
2. Uptake of 203Hg-hydroxy-mercury-fluorescein in myocardial infarcts.
Ramanathan P; Ganatra RD; Daulatram K; Sen PK; Blau M
J Nucl Med; 1971 Sep; 12(9):641-3. PubMed ID: 5571890
[No Abstract] [Full Text] [Related]
3. Studies on the therapeutic use of mercurascan (MSC). Part 2: Antiarrhythmogenic and haemodynamic effect of MSC in experimental myocardial ischaemia.
Málek P; Vrána M; Kolc J; Netusil M; Blazek Z
Int J Clin Pharmacol; 1974 Dec; 10(4):273-82. PubMed ID: 4140846
[No Abstract] [Full Text] [Related]
4. Mercurascan test in ischaemia of the heart muscle caused by permanent ligature of the coronary artery.
Málek P; Kolc J; Vavrejn B; Ratuský J; Kronrád L
Rev Czech Med; 1971; 17(1):11-5. PubMed ID: 5576153
[No Abstract] [Full Text] [Related]
5. Studies on the therapeutic use of Mercurascar. Part III. Influence of Mercurascan on some metabolic changes in experimental myocardial ischaemia in dogs. Section I: Energetic and ionic metabolism.
Kucerová V; Kolc J; Málek P
Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):40-51. PubMed ID: 1150362
[TBL] [Abstract][Full Text] [Related]
6. [Use of a new diagnostic and antiarrhythmic agent, mercurascan, in experimental myocardial infarct].
Malek P; Vavreĭn B; Kolts I; Vrana M; Ratuskiĭ I
Eksp Khir Anesteziol; 1975; (6):3-11. PubMed ID: 1234540
[No Abstract] [Full Text] [Related]
7. [Scintigraphic visualization of cardiac infarct. Experimental studies of the distribution of chloromedrin-Hg203 in the tissues].
Pucci C; Ferri O; Augusti A
Minerva Chir; 1971 Sep; 26(18):1011-23. PubMed ID: 5129423
[No Abstract] [Full Text] [Related]
8. [Complex effect of mercurascan on ischaemia-induced myocardial injury].
Málek P; Kolc J; Vrána M; Kucerová V; Mrhová O; Vránová Z
Cas Lek Cesk; 1975 Jun; 114(25):753-7. PubMed ID: 1157063
[No Abstract] [Full Text] [Related]
9. Studies on the therapeutic use of Mercurascar. Part IV: The effect of Mercurascan on some metabolic changes in experimental myocardial ischaemia. Section II: Enzymes.
Mrhová O; Kolc J; Málek P
Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):52-7. PubMed ID: 125244
[No Abstract] [Full Text] [Related]
10. Metabolism of Mercurascan-203Hg by rats and dogs.
Dreyfuss J; Ross JJ; Shaw JM
J Nucl Biol Med; 1973; 17(2):43-50. PubMed ID: 4754433
[No Abstract] [Full Text] [Related]
11. [Scintiscanning in myocardial infarct using "Mercuroscan"].
Ballaira L
Riv Crit Clin Med; 1968; 68():Suppl 6:947+. PubMed ID: 5747766
[No Abstract] [Full Text] [Related]
12. Protective effect of Mercurascan after coronary artery ligation in the dog.
Málek I; Kolc J; Mrhová O; Urbanová D; Málek P
Eur J Cardiol; 1980; 12(1):55-62. PubMed ID: 7439234
[TBL] [Abstract][Full Text] [Related]
13. [The mercury radioisotope scanning test in myocardial ischemia induced by ligation of the coronary artery].
Málek P; Kolc J; Vavrejn B; Ratuský J; Kronrád L
Cas Lek Cesk; 1970 May; 109(24):542-5. PubMed ID: 5447169
[No Abstract] [Full Text] [Related]
14. [Velocity of the selective accumulation of Mercurascan 203 in injured muscle and in the ischemic myocardium].
Málek P; Vavrejn B; Ratuský J; Kronrád L; Kolc J
Experientia; 1967 Aug; 23(8):649-51. PubMed ID: 6051694
[No Abstract] [Full Text] [Related]
15. [Value of fluorescence in the macroscopic delimitation of experimental acute myocardial ischemia before and after revascularization].
Loisance D; Sadony V; Kaufman H; Sarton MT; Cachera JP
Arch Mal Coeur Vaiss; 1973 Jun; 66(6):701-7. PubMed ID: 4199785
[No Abstract] [Full Text] [Related]
16. The anatomical-functional picture of the vessels in the ischaemic myocardium--a fluorescence investigation.
Borodin YuI ; Polyansky BA; Bikbulatov ZT; Khryachkov VV
Folia Morphol (Praha); 1982; 30(2):192-4. PubMed ID: 7118008
[No Abstract] [Full Text] [Related]
17. Studies on isoprenaline-induced myocardial lesions. 1. Quantitative evaluation by mercurascan uptake.
Faltová E; Mráz M; Kronrád L; Protivová L; Sedivý J
Basic Res Cardiol; 1977; 72(5):454-63. PubMed ID: 588200
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived progenitor cells contribute to lung remodelling after myocardial infarction.
Dupuis J; Préfontaine A; Villeneuve L; Ruel N; Lefebvre F; Calderone A
Cardiovasc Pathol; 2007; 16(6):321-8. PubMed ID: 18005870
[TBL] [Abstract][Full Text] [Related]
19. A new method for radionuclide imaging of myocardial infarcts.
Bonte FJ; Parkey RW; Graham KD; Moore J; Stokely EM
Radiology; 1974 Feb; 110(2):473-4. PubMed ID: 4359008
[No Abstract] [Full Text] [Related]
20. Myocardial uptake studies with 129Cs and the scintillation camera.
Yano Y; Van Dyke D; Budinger TF; Anger HO; Chu P
J Nucl Med; 1970 Nov; 11(11):663-8. PubMed ID: 5476928
[No Abstract] [Full Text] [Related]
[Next] [New Search]
